135 related articles for article (PubMed ID: 38087838)
1. Pulse versus non-pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Hyung K; Lee JH; Kim JY; Choi SM; Park J
Respirology; 2024 Mar; 29(3):235-242. PubMed ID: 38087838
[TBL] [Abstract][Full Text] [Related]
2. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Johkoh T; Fujimoto K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Inomata M; Kamitani T; Yamazaki H; Ogawa Y; Yamamoto Y
Respir Res; 2022 Oct; 23(1):291. PubMed ID: 36289512
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
[TBL] [Abstract][Full Text] [Related]
4. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
[TBL] [Abstract][Full Text] [Related]
6. Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
Sci Rep; 2021 Mar; 11(1):5782. PubMed ID: 33707613
[TBL] [Abstract][Full Text] [Related]
7. High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.
Arai T; Tachibana K; Sugimoto C; Inoue Y; Tokura S; Okuma T; Akira M; Kitaichi M; Hayashi S; Inoue Y
Respirology; 2017 Oct; 22(7):1363-1370. PubMed ID: 28508494
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.
Adams CJ; Chohan K; Rozenberg D; Kavanagh J; Greyling G; Shapera S; Fisher JH
Lung; 2021 Aug; 199(4):379-387. PubMed ID: 34347146
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review.
Novelli L; Ruggiero R; De Giacomi F; Biffi A; Faverio P; Bilucaglia L; Gamberini S; Messinesi G; Pesci A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):385-391. PubMed ID: 28079851
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
Jang HJ; Yong SH; Leem AY; Lee SH; Kim SY; Lee SH; Kim EY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
Sci Rep; 2021 Mar; 11(1):5762. PubMed ID: 33707643
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study.
Kawamura K; Ichikado K; Yasuda Y; Anan K; Suga M
BMC Pulm Med; 2017 Jun; 17(1):94. PubMed ID: 28629448
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial.
Li JS; Zhang HL; Guo W; Wang L; Zhang D; Zhao LM; Zhou M
J Integr Med; 2023 Nov; 21(6):543-549. PubMed ID: 37993378
[TBL] [Abstract][Full Text] [Related]
15. Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Edahiro R; Hamasaki T; Inoue Y;
Respirology; 2019 Jul; 24(7):658-666. PubMed ID: 30835911
[TBL] [Abstract][Full Text] [Related]
16. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study.
Atsumi K; Saito Y; Kuse N; Kobayashi K; Tanaka T; Kashiwada T; Inomata M; Kokuho N; Hayashi H; Kamio K; Fujita K; Abe S; Azuma A; Kubota K; Gemma A
Intern Med; 2018 Mar; 57(5):655-661. PubMed ID: 29151518
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study of 88 patients.
Sakamoto S; Shimizu H; Isshiki T; Kurosaki A; Homma S
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):176-184. PubMed ID: 32476952
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis.
Munson JC; Kreider M; Chen Z; Christie JD; Kimmel SE
Br J Clin Pharmacol; 2010 Jul; 70(1):118-25. PubMed ID: 20642554
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
